Cargando…
Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead
BACKGROUND: The purpose of this study was to evaluate the feasibility of the magnetic resonance (MR) conditional pacemaker (PM) system (Evia SR-T and DR-T with Safio S leads) under MR conditions. METHODS: Patients with standard PM indications and Evia PM were eligible for enrollment in this single c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482396/ https://www.ncbi.nlm.nih.gov/pubmed/23009683 http://dx.doi.org/10.1186/1532-429X-14-67 |
_version_ | 1782247862028992512 |
---|---|
author | Wollmann, Christian G Steiner, Erich Vock, Paul Ndikung, Bonaventure Mayr, Harald |
author_facet | Wollmann, Christian G Steiner, Erich Vock, Paul Ndikung, Bonaventure Mayr, Harald |
author_sort | Wollmann, Christian G |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to evaluate the feasibility of the magnetic resonance (MR) conditional pacemaker (PM) system (Evia SR-T and DR-T with Safio S leads) under MR conditions. METHODS: Patients with standard PM indications and Evia PM were eligible for enrollment in this single center prospective non-randomized pilot study. Patients underwent MR of the brain and lower lumbar spine at 1.5 Tesla. Atrial (RA) und ventricular (RV) lead parameters (sensing, pacing threshold [PTH], pacing impedance) were assessed immediately before (baseline follow-up [FU]) and immediately after MRI (1(st) FU), after 1 month (2(nd) FU) and 3 months (3(rd) FU). The effect of MR on serious adverse device effect (SADE) free-rate, on atrial and ventricular sensing (AS/VS; mV) and atrial (RA) and ventricular (RV) pacing thresholds (PTH; V/0.4 ms) were investigated between baseline and 2(nd) FU. Continuous variables are expressed as mean ± SD and were compared using paired Student’s t-test. A p < 0.05 was considered significant. RESULTS: Thirty-one patients were enrolled. One patient had to be excluded because of an enrollment violation. Therefore, data of 30 patients (female 12 [40%], age 73 ± 12 years, dual chamber PM 15 [50%]) were included in this analysis. No MR related SADE occurred. Lead measurements were not statistically different between the baseline FU and the 2(nd) FU (AS/VS at baseline 3.2 ± 2.1/15.0 ± 6.0, at 2(nd) FU 3.2 ± 2.1/14.9 ± 6.5; p = ns. RA-PTH/RV-PTH at baseline 0.68 ± 0.18/0.78 ± 0.22, at 2(nd) FU 0.71 ± 0.24/0.78 ± 0.22; p = ns). The presence of the permanent pacemakers led to MR imaging artifacts on diffusion weighted sequences of the brain, but did not affect other sequences (e.g. FLAIR and T2 weighted spin-echo images). CONCLUSION: The use of the MR conditional Evia PM in a MR environment under predefined conditions is feasible. No MR related SADEs nor clinically relevant changes in device functions occurred. |
format | Online Article Text |
id | pubmed-3482396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34823962012-10-28 Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead Wollmann, Christian G Steiner, Erich Vock, Paul Ndikung, Bonaventure Mayr, Harald J Cardiovasc Magn Reson Research BACKGROUND: The purpose of this study was to evaluate the feasibility of the magnetic resonance (MR) conditional pacemaker (PM) system (Evia SR-T and DR-T with Safio S leads) under MR conditions. METHODS: Patients with standard PM indications and Evia PM were eligible for enrollment in this single center prospective non-randomized pilot study. Patients underwent MR of the brain and lower lumbar spine at 1.5 Tesla. Atrial (RA) und ventricular (RV) lead parameters (sensing, pacing threshold [PTH], pacing impedance) were assessed immediately before (baseline follow-up [FU]) and immediately after MRI (1(st) FU), after 1 month (2(nd) FU) and 3 months (3(rd) FU). The effect of MR on serious adverse device effect (SADE) free-rate, on atrial and ventricular sensing (AS/VS; mV) and atrial (RA) and ventricular (RV) pacing thresholds (PTH; V/0.4 ms) were investigated between baseline and 2(nd) FU. Continuous variables are expressed as mean ± SD and were compared using paired Student’s t-test. A p < 0.05 was considered significant. RESULTS: Thirty-one patients were enrolled. One patient had to be excluded because of an enrollment violation. Therefore, data of 30 patients (female 12 [40%], age 73 ± 12 years, dual chamber PM 15 [50%]) were included in this analysis. No MR related SADE occurred. Lead measurements were not statistically different between the baseline FU and the 2(nd) FU (AS/VS at baseline 3.2 ± 2.1/15.0 ± 6.0, at 2(nd) FU 3.2 ± 2.1/14.9 ± 6.5; p = ns. RA-PTH/RV-PTH at baseline 0.68 ± 0.18/0.78 ± 0.22, at 2(nd) FU 0.71 ± 0.24/0.78 ± 0.22; p = ns). The presence of the permanent pacemakers led to MR imaging artifacts on diffusion weighted sequences of the brain, but did not affect other sequences (e.g. FLAIR and T2 weighted spin-echo images). CONCLUSION: The use of the MR conditional Evia PM in a MR environment under predefined conditions is feasible. No MR related SADEs nor clinically relevant changes in device functions occurred. BioMed Central 2012-09-25 /pmc/articles/PMC3482396/ /pubmed/23009683 http://dx.doi.org/10.1186/1532-429X-14-67 Text en Copyright ©2012 Wollmann et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wollmann, Christian G Steiner, Erich Vock, Paul Ndikung, Bonaventure Mayr, Harald Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title | Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title_full | Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title_fullStr | Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title_full_unstemmed | Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title_short | Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead |
title_sort | monocenter feasibility study of the mri compatibility of the evia pacemaker in combination with safio s pacemaker lead |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482396/ https://www.ncbi.nlm.nih.gov/pubmed/23009683 http://dx.doi.org/10.1186/1532-429X-14-67 |
work_keys_str_mv | AT wollmannchristiang monocenterfeasibilitystudyofthemricompatibilityoftheeviapacemakerincombinationwithsafiospacemakerlead AT steinererich monocenterfeasibilitystudyofthemricompatibilityoftheeviapacemakerincombinationwithsafiospacemakerlead AT vockpaul monocenterfeasibilitystudyofthemricompatibilityoftheeviapacemakerincombinationwithsafiospacemakerlead AT ndikungbonaventure monocenterfeasibilitystudyofthemricompatibilityoftheeviapacemakerincombinationwithsafiospacemakerlead AT mayrharald monocenterfeasibilitystudyofthemricompatibilityoftheeviapacemakerincombinationwithsafiospacemakerlead |